Metraipolis › archive › dc_492d232fed2f

Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:40860949

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40860949
DOI: 10.2147/jir.s533707
License (as archived): solo-consultazione
Archived: 2026-11-10T11:48:31.026Z
SHA-256 of the archived text: 1ca5ea868f20f8a64882125160fe1fd6a483850b3503d1e94391ee3916343b13
Stable URL of this page: https://metraipolis.com/documento/dc_492d232fed2f

How to cite

Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:40860949 — Europe PMC (en), https://europepmc.org/article/MED/40860949 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_492d232fed2f (Metraipolis archive dc_492d232fed2f, sha256 1ca5ea868f20f8a64882125160fe1fd6a483850b3503d1e94391ee3916343b13)

BibTeX

@misc{dc492d232fed2f,
  title = {Reduced Platelet Aggregation and Plasma Cytokine Levels Mitigate Progressive Metabolic Dysfunction-Associated Steatotic Liver Disease (MASLD) — Europe PMC PMID:40860949},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40860949},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_492d232fed2f; sha256 1ca5ea868f20f8a64882125160fe1fd6a483850b3503d1e94391ee3916343b13},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40860949. Agents can read the archived copy with the MCP tool read_document.